TY  - JOUR 
AU  - Inogès, Susana
AU  - Rodrìguez-Calvillo, Mercedes
AU  - Zabalegui, Natalia
AU  - Lòpez-Dìaz de Cerio, Ascensiòn
AU  - Villanueva, Helena
AU  - Soria, Elena
AU  - Suárez, Lilia
AU  - Rodríguez Caballero, María Arantzazu
AU  - Pastor, Fernando
AU  - García-Muñóz, Ricardo
AU  - Panizo, Carlos
AU  - Pèrez-Calvo, Javier
AU  - Melero, Ignacio
AU  - Rocha, Eduardo
AU  - Orfao de Matos Correia e Vale, José Alberto
AU  - Bendandi, Maurizio
PY  - 2006
SN  - 0027-8874
UR  - http://hdl.handle.net/10366/169315
AB  - [EN]Follicular lymphoma is considered incurable, although cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy can induce sequential remissions. A patient's second complete response is typically shorter than that patient's...
LA  - eng
PB  - Oxford Academic
KW  - Clinical Trial
KW  - Follicular Lymphoma
KW  - Idiotypic vaccination
KW  - Monitoring immune cell response
KW  - Cancer Vaccines
KW  - Disease-Free Survival
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Aged
KW  - Adult
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Lymphoma
KW  - Immunoglobulin Idiotypes
KW  - Matched-Pair Analysis
KW  - Treatment Outcome
KW  - Survival Analysis
KW  - Polymerase Chain Reaction
TI  - Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
T2  - Vaccine Production and Administration
DO  - 10.1093/jnci/djj358
VL  - 98
M2  - 1292
ER  -